Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine Purchase
Washington will pay $1.95 billion to the companies for 100 million doses of their SARS-CoV-2 vaccine -- if it passes muster.
Full Article
Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine Purchase
Motley Fool
0 shares
1 views
You might like
Related news coverage
The bright spot in Trump's coronavirus response
Business Insider
Hello, everyone! Welcome to the new edition of Insider Today. Please sign up here.
..
-
Canadian government has yet to place orders for leading potential COVID vaccines
National Post
-
"We have a winner": Trump administration inks $1.95-billion coronavirus vaccine deal, forcing taxpayers to enrich evil pharma giants
NaturalNews.com
-
FTSE 100 clinging on to gains as sterling rallies
Proactive Investors
-
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors
Advertisement
More coverage
How long will the new, serious Trump last? A week?
Business Insider
Hello, everyone! Welcome to the new edition of Insider Today. Please sign up here.
..
